Salt Baked City invited Utah’s congressional candidates to talk directly to medical cannabis patients about federal cannabis policy. Four candidates shared their views on patient access, state protections and what should change in Washington.

By Benjamin M. Adams

Utah voters will choose four members of the U.S. House of Representatives this November, sending them to Washington at a consequential moment for cannabis policy.

Federal decisions can affect everything from medical cannabis research and veterans’ healthcare to banking, taxation and the ability of states like Utah to operate their own programs. For Utah patients, those decisions can eventually reach all the way to the pharmacy counter.

So Salt Baked City went directly to the candidates.

We invited candidates running in Utah’s four congressional districts to answer the same questions about patient access, state medical cannabis programs, federal priorities and the role patients should play in shaping policy.

Their responses have been shortened for space where necessary, but their words have not been rewritten.

WHAT WE ASKED

  1. Patient Access — What role should the federal government play in protecting patients and supporting state medical cannabis programs?
  2. State Programs — Should states like Utah be able to operate their medical cannabis programs without unnecessary federal interference?
  3. Federal Priorities — Which federal issues—research, veterans’ healthcare, banking, taxation, insurance or access—could have the greatest impact on patients?
  4. Patient Representation — How would you ensure patients and healthcare professionals have a meaningful voice in federal cannabis policy?

BEN McADAMS

Democrat — Congressional District 1

On affordability, banking and federal barriers

“The federal government’s role isn’t to run Utah’s program; its role is to clear away the federal barriers that make our state program more expensive and less safe than it needs to be. That means banking access, fair tax treatment, and support for research so providers and patients have better information about dosing and product options.”

McAdams pointed repeatedly to banking and tax policy as federal issues with a direct effect on patients.

“Banking and tax policy would be my top priority, because they have the most direct effect on what patients actually pay.”

On Utah controlling its own program

“Utahns built this program themselves—through a citizen initiative, tough negotiations at the Capitol, and years of patient advocacy—and I don’t think Washington should second-guess the choices Utah has made about how to run it.”

On giving patients a voice

“Meaningful input means patients and providers get a seat at the table before legislation is drafted, not just a chance to comment after the fact.”

JONNY LARSEN

Democrat — Congressional District 4

On Utah, Prop 2 and federal policy

“This remains a local legislative and states’ rights issue first and foremost. Utah’s medical cannabis patients deserve a more affordable product, and this midterm provides a pathway for that kind of change.”

Larsen argued for federal deregulation while allowing states to determine how their individual programs operate.

“Federally, deregulate it and set a proper framework so patients cannot be taken advantage of. Beyond that, the states should decide.”

On veterans

Larsen brought a personal connection to the issue.

“As a veteran who suffers from chronic pain and other issues, I have spoken to many veterans who use cannabis to help them.”

He said he wants to serve on the Veterans Affairs Committee and change federal restrictions affecting veterans.

“We should work so the VA can permit these conversations now and eventually prescribe, so veterans do not have to pay outside of the VA for their healthcare needs.”

On his experience with Prop 2

“I started a business to create indoor grow lighting, expecting to have customers I could supply a product to. When the original Prop 2 was changed, it forced me to stop.”

JESSE WEST

Libertarian — Congressional District 1

On the federal government’s role

West’s responses consistently emphasized individual rights and sharply limiting federal cannabis restrictions.

“The Federal government should either greatly reduce restrictions on cannabis or completely eliminate restrictions. This would allow the states to operate freely.”

On legalization

“I am for full cannabis legalization and ensuring that the federal government does not stand in the way of progress.”

On patient representation

West also identified himself as a patient.

“Also, as a patient myself, I can stay involved through continued interaction with the system.”

TAYLOR WRIGHT

Libertarian — Congressional District 4

On healthcare and prohibition

“Healthcare decisions belong to patients and their doctors—not politicians, bureaucrats, or federal agencies.”

Wright argued that reducing federal involvement would improve access and competition.

“Competition and free markets—not government control—are the best way to lower prices, increase innovation, and expand access to quality medical cannabis for patients.”

On federal cannabis policy

“The greatest impact would come from ending federal prohibition altogether.”

On personal liberty

“I believe adults own their own bodies. As long as someone is not violating the rights of another person, the government should not be making their personal medical decisions.”

ABOUT THE QUESTIONNAIRE

Salt Baked City invited candidates across Utah’s four congressional districts to answer the same questions about patient access, state medical cannabis programs, federal priorities and the role patients should play in shaping policy.


READ THEIR COMPLETE ANSWERS

Space is tight in print. Democracy shouldn’t be.

Read each candidate’s full response to the Salt Baked City 2026 Medical Cannabis Policy Questionnaire at SaltBakedCity.com.

https://www.cannazipbags.com/